PFG
67
2
ACN
50
-6
AZO
48
-2
SE
47
-2
SIG
44
3
KO
44
-2
APD
52
-2
LMT
50
3
CMCSA
32
-10
MAR
59
-6
TGNA
48
-2
XOM
48
-12
TRIP
60
2
ORLY
48
-2
EMR
70
2
ETN
65
-2
XRX
37
-2
CA
21
6
SO
53
-4
D
37
-6
PFG
67
2
ACN
50
-6
AZO
48
-2
SE
47
-2
SIG
44
3
KO
44
-2
APD
52
-2
LMT
50
3
CMCSA
32
-10
MAR
59
-6
TGNA
48
-2
XOM
48
-12
TRIP
60
2
ORLY
48
-2
EMR
70
2
ETN
65
-2
XRX
37
-2
CA
21
6
SO
53
-4
D
37
-6
Financhill
Back

Edgewise Therapeutics, Inc. 10K Form

Buy
66

EWTX
Edgewise Therapeutics, Inc.

Last Price:
$23.59
Seasonality Move:
33.89%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive EWTX News And Ratings

See the #1 stock for the next 7 days that we like better than EWTX

EWTX Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-34.9M
Price / Cash Flow: 0
Annual Sales: $5.28
Price / Book: 4.47

Profitability

EPS (TTM): -1.57730
Net Income (TTM): $-157.2M
Gross Margin: $-2.3M
Return on Equity: -31.13%
Return on Assets: -29.68%

Edgewise Therapeutics, Inc. Earnings Forecast

Key Edgewise Therapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 6 years have been positive in 1 years.

Edgewise Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: EWTX
Website: edgewisetx.com

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 26.51
Quick Ratio: 26.03

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

EWTX Technical Analysis vs Fundamental Analysis

Buy
66
Edgewise Therapeutics, Inc. (EWTX) is a Buy

Is Edgewise Therapeutics, Inc. a Buy or a Sell?